Medical Article

Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company’s website, with prices ranging from $35 to $59. The post Evvy Introduces Treatments for Common Vaginal Symptoms appeared first on MedCity News.

Real-time access to clinical data would reduce the wasted time and effort tracking down referral records and enable a more proactive, rather than reactive, approach to patient treatment plans.   The post DPC Physicians Are Running Blind Without Clinical Data appeared first on MedCity News.

[Sponsored] The 2025 Benefits Sentiment Index is based on a survey of 120 benefit consultants to self-insured employers and is sponsored by Quantum Health. The post Report Finds Healthcare Navigation Is at a Crossroads appeared first on MedCity News.

Neuroflow acquired Intermountain Health’s behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on…

Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits. The post Capital Rx Rebrands as Judi Health After Securing $400M Investment appeared first on MedCity News.

Months before the FTC sued the three largest pharmacy benefit managers, the CEO of Blue Shield of California battled its PBM – CVS Caremark – to bring a lower cost prostate cancer drug to its members. The post Video: Why the FTC’s Lawsuit Against PBMs May Have Some Legs appeared first on MedCity News.